Celine Tissot-Robert
Toronto, ON M5G2C1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.
Journal: Cancer discovery
Published: February 02, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Journal: Lancet (London, England)
Published: August 09, 2023
High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
Journal: Journal for immunotherapy of cancer
Published: July 25, 2019
IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function.
Journal: Cancer immunology research
Published: July 08, 2019
Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer.
Journal: Oncoimmunology
Published: April 03, 2019
Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy.
Journal: Cancer research
Published: October 16, 2017
Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo.
Journal: PLoS biology
Published: August 24, 2017
IRF4 and BATF are critical for CD8⁺ T-cell function following infection with LCMV.
Journal: Cell death and differentiation
Published: October 29, 2013
Mobilizing and evaluating anticancer T cells: pitfalls and solutions.
Journal: Expert review of vaccines
Published: October 17, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026